{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:35:20Z","timestamp":1789792520547,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.drudis.2026.104655","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:28:28Z","timestamp":1774970908000},"page":"104655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Foundation models and AI agents in oncology drug discovery"],"prefix":"10.1016","volume":"31","author":[{"given":"Yashwardhan","family":"Ghanwatkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Rajdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3588-0434","authenticated-orcid":false,"given":"Ram I.","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104655_b0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrclinonc.2011.34","article-title":"High drug attrition rates\u2014where are we going wrong?","volume":"8","author":"Hutchinson","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.drudis.2026.104655_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.insi.2025.100049","article-title":"Artificial intelligence (AI) in drug design and discovery: a comprehensive review","volume":"1","author":"Bhat","year":"2025","journal-title":"In Silico Res Biomed"},{"key":"10.1016\/j.drudis.2026.104655_b0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104655_b0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.drudis.2020.12.009","article-title":"Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet","volume":"26","author":"Bender","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104655_b0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104655_b0030","doi-asserted-by":"crossref","DOI":"10.1093\/pcmedi\/pbaf015","article-title":"AlphaFold 3: an unprecedent opportunity for fundamental research and drug development","volume":"8","author":"Fang","year":"2025","journal-title":"Precis Clin Med"},{"issue":"5","key":"10.1016\/j.drudis.2026.104655_b0035","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1039\/D5SC06481C","article-title":"Unlocking the application potential of AlphaFold3-like approaches in virtual screening","volume":"17","author":"Shen","year":"2025","journal-title":"Chem Sci"},{"key":"10.1016\/j.drudis.2026.104655_b0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.abj8754","article-title":"Accurate prediction of protein structures and interactions using a three-track neural network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.drudis.2026.104655_b0045","article-title":"Intrinsically disordered regions in the transcription factor MYC:MAX modulate DNA binding via intramolecular interactions","author":"Sch\u00fctz","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104655_b0050","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41592-024-02201-0","article-title":"scGPT: toward building a foundation model for single-cell multi-omics using generative AI","volume":"21","author":"Cui","year":"2024","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104655_b0055","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20188746","article-title":"Current best practices in single\u2010cell RNA\u2010seq analysis: a tutorial","volume":"15","author":"Luecken","year":"2019","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.drudis.2026.104655_b0060","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/s41592-023-01969-x","article-title":"Learning single-cell perturbation responses using neural optimal transport","volume":"20","author":"Bunne","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.drudis.2026.104655_b0065","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1016\/j.cell.2024.09.044","article-title":"Method of moments framework for differential expression analysis of single-cell RNA sequencing data","volume":"187","author":"Kim","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104655_b0070","first-page":"1","article-title":"Distinguishing cause from effect using observational data: methods and benchmarks","volume":"17","author":"Mooij","year":"2016","journal-title":"J Machine Learn Res"},{"key":"10.1016\/j.drudis.2026.104655_b0075","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/s12276-025-01547-5","article-title":"Single-cell foundation models: bringing artificial intelligence into cell biology","volume":"57","author":"Baek","year":"2025","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.drudis.2026.104655_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2025.100213","article-title":"Generative AI for drug discovery and protein design: the next frontier in AI-driven molecular science","volume":"27","author":"Das","year":"2025","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.drudis.2026.104655_b0085","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2026.104655_b0090","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/cn3000422","article-title":"Exploring chemical space for drug discovery using the chemical universe database","volume":"3","author":"Reymond","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.drudis.2026.104655_b0095","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1021\/acs.jcim.5c00641","article-title":"Generative deep learning for de novo drug design \u2013 a chemical space Odyssey","volume":"65","author":"\u00d6z\u00e7elik","year":"2025","journal-title":"J Chem Inf Model"},{"issue":"23","key":"10.1016\/j.drudis.2026.104655_b0100","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.3390\/ijms262311443","article-title":"Deep Generative AI for Multi-Target Therapeutic Design: Toward Self-Improving Drug Discovery Framework","volume":"26","author":"Kang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104655_b0105","article-title":"Diffdock: diffusion steps, twists, and turns for molecular docking","author":"Corso","year":"2022","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104655_b0110","doi-asserted-by":"crossref","first-page":"23889","DOI":"10.1021\/acsomega.5c00549","article-title":"AI-driven drug discovery: a comprehensive review","volume":"10","author":"Ferreira","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.drudis.2026.104655_b0115","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1039\/D3SC04185A","article-title":"PoseBusters: AI-based docking methods fail to generate physically valid poses or generalise to novel sequences","volume":"15","author":"Buttenschoen","year":"2024","journal-title":"Chem Sci"},{"key":"10.1016\/j.drudis.2026.104655_b0120","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1021\/acs.jcim.5c01203","article-title":"In search of beautiful molecules: a perspective on generative modeling for drug design","volume":"65","author":"van den Broek","year":"2025","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.drudis.2026.104655_b0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2415665122","article-title":"Generative AI for navigating synthesizable chemical space","volume":"122","author":"Gao","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.drudis.2026.104655_b0130","doi-asserted-by":"crossref","DOI":"10.1039\/D5MD00672D","article-title":"Accelerating compound synthesis in drug discovery: the role of digitalisation and automation","author":"Nippa","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.drudis.2026.104655_b0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2478\/acph-2019-0024","article-title":"Metabolic stability and its role in the discovery of new chemical entities","volume":"69","author":"S\u0142oczy\u0144ska","year":"2019","journal-title":"Acta Pharm"},{"key":"10.1016\/j.drudis.2026.104655_b0140","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104655_b0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13321-025-01059-4","article-title":"Generative artificial intelligence based models optimization towards molecule design enhancement","volume":"17","author":"Khater","year":"2025","journal-title":"J Cheminform"},{"key":"10.1016\/j.drudis.2026.104655_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104512","article-title":"Gaps between medical biology and AI drug discovery","volume":"30","author":"Yin","year":"2025","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.drudis.2026.104655_b0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s42004-026-01932-9","article-title":"The ADePT framework for assessing autonomous laboratory robotics","volume":"9","author":"Salazar-Villacis","year":"2026","journal-title":"Commun Chem"},{"key":"10.1016\/j.drudis.2026.104655_b0160","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"2","key":"10.1016\/j.drudis.2026.104655_b0165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/biom16020325","article-title":"Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms","volume":"16","author":"Faryal","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2026.104655_b0170","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1021\/acs.jcim.0c00589","article-title":"PRosettaC: Rosetta based modeling of PROTAC mediated ternary complexes","volume":"60","author":"Zaidman","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.drudis.2026.104655_b0175","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1038\/s41467-022-33575-4","article-title":"Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry","volume":"13","author":"Dixon","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104655_b0180","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/acsbiomedchemau.2c00037","article-title":"Modeling the effect of cooperativity in ternary complex formation and targeted protein degradation mediated by heterobifunctional degraders","volume":"3","author":"Park","year":"2023","journal-title":"ACS Bio Med Chem Au"},{"key":"10.1016\/j.drudis.2026.104655_b0185","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.cell.2020.10.038","article-title":"Mapping the degradable kinome provides a resource for expedited degrader development","volume":"183","author":"Donovan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104655_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108399","article-title":"Advancing microbial production through artificial intelligence-aided biology","volume":"74","author":"Gong","year":"2024","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.drudis.2026.104655_b0195","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein degradation: expanding the toolbox","volume":"18","author":"Schapira","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104655_b0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104655_b0205","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.gpb.2022.11.008","article-title":"Machine learning modeling of protein-intrinsic features predicts tractability of targeted protein degradation","volume":"20","author":"Zhang","year":"2022","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.drudis.2026.104655_b0210","article-title":"Accelerating drug discovery through agentic AI: a multi-agent approach to laboratory automation in the DMTA cycle","author":"Fehlis","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104655_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32110588","article-title":"Artificial intelligence in clinical oncology: from productivity enhancement to creative discovery","volume":"32","author":"Kuno","year":"2025","journal-title":"Curr Oncol"},{"key":"10.1016\/j.drudis.2026.104655_b0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-026-03035-1","article-title":"Agentic AI and the rise of in silico team science in biomedical research","author":"Li","year":"2026","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.drudis.2026.104655_b0225","article-title":"TxAgent: an AI agent for therapeutic reasoning across a universe of tools","author":"Gao","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104655_b0230","doi-asserted-by":"crossref","first-page":"12534","DOI":"10.1021\/jacs.4c17738","article-title":"A multiagent-driven robotic AI chemist enabling autonomous chemical research on demand","volume":"147","author":"Song","year":"2025","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2026.104655_b0235","article-title":"From task executors to research partners: evaluating AI co-pilots through workflow integration in biomedical research","author":"Weidener","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104655_b0240","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-023-06792-0","article-title":"Autonomous chemical research with large language models","volume":"624","author":"Boiko","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104655_b0245","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.matt.2023.02.007","article-title":"Self-driving laboratories: a paradigm shift in nanomedicine development","volume":"6","author":"Hickman","year":"2023","journal-title":"Matter"},{"key":"10.1016\/j.drudis.2026.104655_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104009","article-title":"How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons","volume":"29","author":"Kp Jayatunga","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104655_b0255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40364-025-00758-2","article-title":"Integrating artificial intelligence in drug discovery and early drug development: a transformative approach","volume":"13","author":"Ocana","year":"2025","journal-title":"Biomark Res"},{"key":"10.1016\/j.drudis.2026.104655_b0260","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1038\/s41591-025-03743-2","article-title":"A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial","volume":"31","author":"Xu","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2026.104655_b0265","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ccell.2021.04.002","article-title":"Artificial intelligence for clinical oncology","volume":"39","author":"Kann","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2026.104655_b0270","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamadermatol.2024.2701","article-title":"Tyrosine kinase 2 inhibition with zasocitinib (TAK-279) in psoriasis: a randomized clinical trial","volume":"160","author":"Armstrong","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.drudis.2026.104655_b0275","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.2024.21451","article-title":"FDA perspective on the regulation of artificial intelligence in health care and biomedicine","volume":"333","author":"Warraich","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2026.104655_b0280","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41746-024-01232-3","article-title":"Navigating the EU AI Act: implications for regulated digital medical products","volume":"7","author":"Aboy","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.drudis.2026.104655_b0285","doi-asserted-by":"crossref","DOI":"10.2196\/43251","article-title":"Human-centered design to address biases in artificial intelligence","volume":"25","author":"Chen","year":"2023","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.drudis.2026.104655_b0290","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41746-023-00918-4","article-title":"A translational perspective towards clinical AI fairness","volume":"6","author":"Liu","year":"2023","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.drudis.2026.104655_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2025.101290","article-title":"Advancing ethical AI in healthcare through interpretability","volume":"6","author":"Ning","year":"2025","journal-title":"Patterns"},{"key":"10.1016\/j.drudis.2026.104655_b0300","article-title":"X-Atlas\/Orion: genome-wide perturb-seq datasets via a scalable fix-cryopreserve platform for training dose-dependent biological foundation models","author":"Huang","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104655_b0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01481-x","article-title":"Combinatorial prediction of therapeutic perturbations using causally inspired neural networks","author":"Gonzalez","year":"2025","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.drudis.2026.104655_b0310","article-title":"Large-scale causal discovery using interventional data sheds light on the regulatory network architecture of blood traits","author":"Brown","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104655_b0315","article-title":"Causal modeling of gene effects from regulators to programs to traits: integration of genetic associations and Perturb-seq","author":"Ota","year":"2025","journal-title":"RbioRxiv."},{"key":"10.1016\/j.drudis.2026.104655_b0320","article-title":"AI-Driver: an ensemble method for identifying driver mutations in personal cancer genomes","volume":"2","author":"Wang","year":"2020","journal-title":"NAR Genom Bioinform"},{"key":"10.1016\/j.drudis.2026.104655_b0325","article-title":"Tahoe-100M: a giga-scale single-cell perturbation atlas for context-dependent gene function and cellular modeling","author":"Zhang","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104655_b0330","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1016\/j.bpj.2023.04.006","article-title":"Building the next generation of virtual cells to understand cellular biology","volume":"122","author":"Johnson","year":"2023","journal-title":"Biophys J"},{"key":"10.1016\/j.drudis.2026.104655_b0335","article-title":"Towards an AI co-scientist","author":"Gottweis","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104655_b0340","article-title":"rbio1-training scientific reasoning LLMs with biological world models as soft verifiers","author":"Istrate","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104655_b0345","article-title":"Quantum computing-enhanced algorithm unveils novel inhibitors for KRAS","author":"Vakili","year":"2024","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104655_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104878","article-title":"Artificial intelligence in molecular optimization: current paradigms and future frontiers","volume":"26","author":"Xia","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104655_b0355","article-title":"Bio-inspired AI: integrating biological complexity into artificial intelligence","author":"Dehghani","year":"2024","journal-title":"arXiv"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:24:01Z","timestamp":1785947041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1359644626000607"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104655","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Foundation models and AI agents in oncology drug discovery","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104655"}}